Quantcast

Latest dialysis Stories

2014-05-19 08:28:07

LAWRENCE, Mass., May 19, 2014 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, is proud to share a current NxStage® System One(TM) user's story of courage, persistence and determination. Despite losing both of his kidneys to cancer, Greg, a 65-year-old avid runner, was able to accomplish his goal of running a half marathon this past February in Sacramento. For Greg, more frequent home hemodialysis (HHD) with the NxStage...

2014-05-17 23:03:54

ResearchMoz.us includes new market research report "Facial Aesthetics Market to 2020: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports. Browse Full Report with TOC at: http://www.researchmoz.us/facial-aesthetics-market-to-2020-economic-recovery-drives-growth-in-the-us-as-increasing-awareness-fuels-demand-in-developing-markets-report.html Albany, NY (PRWEB) May 17, 2014 The Report provides comprehensive information on the...

2014-05-15 23:08:44

ChinaMarketResearchReports.com adds "Global and China Hemodialysis Industry Report, 2013-2016" market research, on hemodialysis service market and hemodialysis equipment market, to its store. Dallas, TX (PRWEB) May 15, 2014 Global and China Hemodialysis Industry Report, 2013-2016 market research says in 2013, the global number of patients receiving dialysis continued to grow to 2.519 million. The new patients mainly come from Asia Pacific region (excluding Japan). Europe,...

2014-05-15 08:32:20

Study will evaluate tenapanor for the treatment of hyperphosphatemia in ESRD patients on hemodialysis FREMONT, Calif., May 15, 2014 /PRNewswire/ -- Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, GI and metabolic diseases, today announced that it has received a $25 million milestone payment from AstraZeneca (NYSE:AZN, LON:AZN) for the initiation of a Phase 2b clinical trial evaluating tenapanor for the treatment of hyperphosphatemia, or elevated...

2014-05-14 16:28:26

RIVER EDGE, N.J., May 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today that John C. Houghton, President and Chief Executive Officer, will present at the Third Annual Marcum MicroCap Conference in New York on Thursday, May 29, 2014 at 3:30 p.m. EDT....

2014-05-14 16:28:23

RIVER EDGE, N.J., May 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months ended March 31, 2014. Recent Highlights -- Commenced shipment of our NanoGuard-D and NanoGuard-S ultrafilters -- Extended and...

2014-05-13 16:28:05

RIVER EDGE, N.J., May 13, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today the first commercial use of its hemodiafiltration ("HDF") system in the United States. As announced in a separate press release today, DaVita Kidney Care, a division of DaVita...

2014-05-13 08:31:01

Hemodiafiltration Trial Launches in Colorado Springs DENVER, May 13, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced it is now delivering hemodiafiltration treatments to select patients in Colorado Springs as part of a six-month trial program. This marks the first delivery of hemodiafiltration in the United States....

2014-05-12 12:31:13

Patient Pathways, VillageHealth Recognized with National Awards DENVER, May 12, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that its approach to integrated care has been recognized with two Dorland Health "Case In Point" Platinum Awards, a unique awards program that recognizes the most successful and innovative case-management programs working to improve...

2014-05-09 13:37:38

American Society of Nephrology More frequent face-to-face physician visits in the month following hospital discharge may help reduce a kidney failure patient's chances of needing to be sent back to the hospital. That's the conclusion of a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The study also found that closer outpatient monitoring of kidney failure patients following hospital discharge could cut health care costs significantly....


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.